Insights into the place of fulvestrant for the treatment of advanced endocrine responsive breast cancer. [electronic resource]
Producer: 20101108Description: 4548-50 p. digitalISSN:- 1527-7755
- Antineoplastic Agents, Hormonal -- administration & dosage
- Breast Neoplasms -- chemistry
- Clinical Trials, Phase III as Topic
- Disease-Free Survival
- Drug Administration Schedule
- Estradiol -- administration & dosage
- Estrogen Antagonists -- administration & dosage
- Female
- Fulvestrant
- Humans
- Injections, Intramuscular
- Middle Aged
- Multicenter Studies as Topic
- Postmenopause
- Quality of Life
- Randomized Controlled Trials as Topic
- Receptors, Estrogen -- analysis
- Risk Assessment
- Risk Factors
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Editorial; Comment
There are no comments on this title.
Log in to your account to post a comment.